Dow Up 0.51% Nasdaq Up 0.24%

Regulus Therapeutics Inc. (RGLS)

-NasdaqGM
16.23 Up 0.54(3.44%) Nov 21, 4:00PM EST
|After Hours : 16.23 Up 0.00 (0.01%) Nov 21, 4:45PM EST
Prev Close:15.69
Open:15.94
Bid:14.00 x 1000
Ask:N/A
1y Target Est:22.60
Beta:1.79
Next Earnings Date:N/A
Day's Range:15.50 - 16.27
52wk Range:5.40 - 25.60
Volume:683,101
Avg Vol (3m):1,425,900
Market Cap:788.83M
P/E (ttm):N/A
EPS (ttm):-0.85
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for RGLS

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):85.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-1.02
Quarterly EPS Est (Dec-14) :-0.21
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regulus Therapeutics Inc., a biopharmaceutical company, focuses on the discovery and development of drugs that target microRNAs for the treatment of various diseases in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback